The Immunoassay Market is projected to expand at a compound annual growth rate (CAGR) of 6% from 2022 to 2032, with an anticipated market value of US$ 53 billion by the end of the forecast period. In 2021, the market reached US$ 28 billion, and it is expected to achieve US$ 29.6 billion in 2022, reflecting a year-on-year (Y-o-Y) growth of 5.7%. The market's growth can be attributed...